Acute Agitation Completed Phase 4 Trials for Asenapine (DB06216)

Also known as: Agitation / Excitement abnormal / Feeling agitated / Agitated

IndicationStatusPhase
DBCOND0078942 (Acute Agitation)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01400113Treating Acutely Agitated Patients With Asenapine Sublingual TabletsTreatment